Informatie:
Fout:
ID
21149
Beschrijving
Comparison of IPX054, Immediate-Release Carbidopa-Levodopa, and Controlled-Release Carbidopa-Levodopa in Subjects With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00279825
Link
https://clinicaltrials.gov/show/NCT00279825
Trefwoorden
Versies (1)
- 11-04-17 11-04-17 -
Geüploaded op
11 april 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Idiopathic Parkinson's Disease NCT00279825
Eligibility Idiopathic Parkinson's Disease NCT00279825
- StudyEvent: Eligibility
Similar models
Eligibility Idiopathic Parkinson's Disease NCT00279825
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Parkinson Disease
Item
diagnosed with idiopathic parkinson's disease.
boolean
C0030567 (UMLS CUI [1])
Carbidopa / Levodopa Immediate Release | Carbidopa / Levodopa Controlled Release | Levodopa Dose
Item
currently being treated with immediate-release or controlled-release carbidopa-levodopa and not requiring more than 200 mg levodopa per dose.
boolean
C0353697 (UMLS CUI [1,1])
C1708470 (UMLS CUI [1,2])
C0353697 (UMLS CUI [2,1])
C1707506 (UMLS CUI [2,2])
C0023570 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C1708470 (UMLS CUI [1,2])
C0353697 (UMLS CUI [2,1])
C1707506 (UMLS CUI [2,2])
C0023570 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
Wearing off effect Pharmaceutical Preparations Dosage
Item
must experience "wearing off" between doses of medication.
boolean
C1504539 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0013227 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Atypical Parkinson Disease
Item
diagnosed with atypical parkinsonism.
boolean
C1868596 (UMLS CUI [1])
Carbidopa + levodopa allergy | Carbidopa / Levodopa Absent response to treatment
Item
allergic or non-responsive to previous carbidopa-levodopa therapy.
boolean
C0570732 (UMLS CUI [1])
C0353697 (UMLS CUI [2,1])
C0438286 (UMLS CUI [2,2])
C0353697 (UMLS CUI [2,1])
C0438286 (UMLS CUI [2,2])
Angle Closure Glaucoma | Glaucoma, Open-Angle
Item
active or history of narrow-angle or wide-angle glaucoma.
boolean
C0017605 (UMLS CUI [1])
C0017612 (UMLS CUI [2])
C0017612 (UMLS CUI [2])
Seizures | Epilepsy | Anticonvulsants
Item
history of seizure or epilepsy, or is currently taking an anti-convulsant for treatment of seizures.
boolean
C0036572 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
C0003286 (UMLS CUI [3])
C0014544 (UMLS CUI [2])
C0003286 (UMLS CUI [3])
Antipsychotic Agents | Antipsychotic Agents Atypical
Item
treatment with any neuroleptic agent, including atypical neuroleptics, within the previous 12 months.
boolean
C0040615 (UMLS CUI [1])
C0040615 (UMLS CUI [2,1])
C0205182 (UMLS CUI [2,2])
C0040615 (UMLS CUI [2,1])
C0205182 (UMLS CUI [2,2])
Dopamine Antagonists
Item
treatment with any dopaminergic blocking agent within the previous 3 months.
boolean
C0242702 (UMLS CUI [1])